Details of the Drug

General Information of Drug (ID: DMUUTE9)

Drug Name

PF-06647263

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02078752) A Study Of PF-06647263 In Patients With Advanced Solid Tumors. U.S. National Institutes of Health.